These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2754065)
1. Facial telangiectasia associated with long-term application of a topical corticosteroid to the scalp. Hogan DJ; Rooney ME J Am Acad Dermatol; 1989 Jun; 20(6):1129-30. PubMed ID: 2754065 [No Abstract] [Full Text] [Related]
3. The effect of topical steroid application on natural killer cell activity. Lesko MJ; Lever RS; Mackie RM; Parrott DM Clin Exp Allergy; 1989 Nov; 19(6):633-6. PubMed ID: 2598103 [TBL] [Abstract][Full Text] [Related]
4. Cushing's syndrome after topical application of corticosteroids. Ruiz-Maldonado R; Zapata G; Lourdes T; Robles C Am J Dis Child; 1982 Mar; 136(3):274-5. PubMed ID: 7064956 [No Abstract] [Full Text] [Related]
5. Comparison of topical treatment with desoxymethasone solution 0.25% with salicylic acid 1% and betamethasone valerate solution 0.1% in patients with psoriasis of the scalp. Hillström L J Int Med Res; 1984; 12(3):170-3. PubMed ID: 6734919 [TBL] [Abstract][Full Text] [Related]
6. Once daily application of diflorasone diacetate ointment compared with betamethasone valerate ointment twice daily in patients with eczematous dermatoses. Hersle K; Mobacken H J Int Med Res; 1982; 10(6):423-5. PubMed ID: 7152081 [TBL] [Abstract][Full Text] [Related]
7. Application of topical corticosteroids. Mörtenhumer M; Oikarinen A Arch Dermatol; 1985 Aug; 121(8):971. PubMed ID: 4026355 [No Abstract] [Full Text] [Related]
8. Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream. Magnus AD; Haigh JM; Kanfer I Dermatologica; 1981; 163(4):331-7. PubMed ID: 7308554 [TBL] [Abstract][Full Text] [Related]
9. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%. Fischer GO Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951 [No Abstract] [Full Text] [Related]
13. Treatment of melasma (chloasma) by local application of a steroid cream. Neering H Dermatologica; 1975; 151(6):349-53. PubMed ID: 1228009 [TBL] [Abstract][Full Text] [Related]
14. Influence of topically applied betamethasone-17-valerate on cell cycle kinetics of human anagen hair determined by DNA flow cytometry. Schell H; Kiesewetter F; Pausch C; Arai A; Katsuoka K; Hornstein OP Dermatologica; 1989; 178(1):12-5. PubMed ID: 2917676 [TBL] [Abstract][Full Text] [Related]
15. Brimonidine for treatment of telangiectasia of dermatomyositis. Yap FHX; Kumarasinghe SP Australas J Dermatol; 2018 Aug; 59(3):e220-e221. PubMed ID: 28960234 [No Abstract] [Full Text] [Related]
16. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate. Passarella E; Milanino R Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688 [TBL] [Abstract][Full Text] [Related]
17. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules. Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214 [TBL] [Abstract][Full Text] [Related]
18. Adverse reaction to a topical steroid transferred by physical contact. Stankler L; Bewsher PD Br Med J; 1978 Aug; 2(6134):399-400. PubMed ID: 567511 [No Abstract] [Full Text] [Related]
19. Contact allergic reaction to valerate esters of betamethasone and hydrocortisone. Koch EM Contact Dermatitis; 1985 Jan; 12(1):58. PubMed ID: 3979047 [No Abstract] [Full Text] [Related]
20. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application. Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]